AISAP Cardio vs Ligence Heart
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if your primary need is rapid, AI-powered cardiac diagnostic assessments performed directly at the patient's bedside using point-of-care ultrasound (POCUS). This tool is ideal for clinicians requiring immediate, comprehensive insights into structural heart disease and heart failure for early detection and intervention in diverse clinical settings.
View AISAP Cardio →Choose Ligence Heart if…
Choose Ligence Heart if your objective is to significantly enhance the efficiency and accuracy of analyzing and reporting standard 2D transthoracic echocardiography studies within a cardiology department or imaging lab. This platform is best suited for automating complex measurements, view classifications, and report generation from existing PACS images, thereby streamlining the workflow for cardiologists and sonographers.
View Ligence Heart →When choosing between AISAP Cardio and Ligence Heart, physicians should consider their primary use case and existing workflow. AISAP Cardio is designed for point-of-care ultrasound (POCUS), excelling at rapid, comprehensive cardiac diagnostic assessments directly at the bedside. It provides immediate AI-powered interpretations for early detection of structural heart disease and heart failure, including detailed measurements of various cardiac structures and valvular pathologies. This tool is best suited for emergency medicine physicians, cardiologists, or radiologists who require quick, on-the-spot cardiac insights and automated reporting at the point of care.
In contrast, Ligence Heart is a web-based platform focused on automating the analysis and reporting of 2D transthoracic echocardiography. Its strengths lie in enhancing diagnostic efficiency and accuracy for cardiologists and sonographers by automating image recognition, view classification, heart phase prediction, and a wide range of measurements, including strain and Doppler. The key practical difference is AISAP Cardio’s emphasis on real-time POCUS assessments versus Ligence Heart’s focus on post-acquisition analysis and reporting of standard echocardiograms. Physicians prioritizing immediate bedside diagnostics and comprehensive POCUS capabilities would lean towards AISAP Cardio, while those seeking to streamline and automate the detailed analysis and reporting of their existing echocardiography studies will find Ligence Heart more aligned with their needs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | Ligence Heart |
|---|---|---|
| Pricing | Not publicly available | Contact-for-pricing |
| Deployment | Cloud-based SaaS platform | Cloud-based; on-premise; hybrid |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AISAP CardioAISAP Cardio focuses on point-of-care ultrasound (POCUS) at the bedside, designed for rapid assessments by both cardiologists and non-cardiologists. Its real-time guidance features are praised by users for improving diagnostic accuracy and speeding up time-to-diagnosis, making advanced diagnostics more accessible to a wider range of clinicians.
Clinical Value
Ligence HeartBoth tools are FDA-cleared and clinically validated. Ligence Heart demonstrates superior comprehensive diagnostic depth by automating a broader range of advanced 2D TTE measurements, including strain and LV mass, with studies showing its AI can outperform human measurements and offers no variability. While AISAP Cardio excels in early detection at the bedside for non-cardiologists, Ligence's comprehensive automation for full echocardiograms provides a higher overall diagnostic consistency and depth.
Pricing & Value
TieNeither AISAP Cardio nor Ligence Heart publicly discloses its pricing model, both requiring direct contact for demos and quotes. This lack of transparency for both tools makes a direct comparison of their pricing or an assessment of their value proposition impossible.
Enterprise Readiness
Ligence HeartLigence Heart explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA) in its structured facts, and offers flexible deployment options including cloud, on-premise, and hybrid solutions. While AISAP Cardio uses a HIPAA-compliant and ISO-certified cloud, Ligence's explicit declarations in the primary data and broader deployment flexibility provide a stronger indication of enterprise readiness for diverse IT environments.
Innovation
AISAP CardioAISAP Cardio is recognized as the world's first real-time AI-powered cardiac diagnostic platform for POCUS, enabling expert-level diagnostics at the patient's bedside by a broader range of clinicians, including non-cardiologists. This focus on democratizing advanced cardiac diagnostics at the point of care represents a more disruptive innovation in terms of accessibility and potential for early intervention compared to Ligence Heart's comprehensive automation of post-acquisition analysis.
Support & Docs
Ligence HeartLigence Heart provides explicit contact information for technical support ([email protected]) and mentions the availability of Instructions for Use (IFU) and training videos for operators. AISAP Cardio's information regarding specific support channels or documentation is not readily available in the provided facts or search results, indicating less transparency in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | Ligence Heart |
|---|---|---|
| Product Name | AISAP Cardio | Ligence Heart |
| Company | Aisap | Ligence |
| Primary Use Case Summary | AI-powered point-of-care ultrasound (POCUS) software for rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy. |
| Key Feature: Automated Measurements | Left Ventricle Ejection Fraction (LVEF), right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. | Area, Distance, Doppler, and Volume quantification; Automated strain, Spectral and Tissue Doppler measurements. |
| Key Feature: Disease Recognition | Early cardiac disease detection, valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), structural heart disease, and heart failure. | Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases. |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and Ligence Heart.